Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 4, Issue 1 (2015)

Differential Access to Treating Of Drug-Induced Hepatotoxicity in Patients with Chronic Lymphocytic Leukemia

Author(s):
Grydguk T.І.
Abstract:
In this article abilities of differential administration of hepatoprotective medications are observed regarding a type of drug-induced liver injury during chemotherapy in patients with chronic lymphocytic leukemia. The type of drug-induced liver injury was determined depending on the grade of increasing of aminotransferase and alkaline phosphatase levels. Effectiveness of arginine glutamate at presence of cytolitic type of drug-induced liver injury and ursosan at presence of cholestatic type of drug-induced liver injury was studied. It was determined that including of these medicines in basic therapy of drug-induced liver injury promotes normalization of biochemical indexes that characterize functional state of liver parenchyma and enables to provide chemotherapy courses of chronic lymphocytic leukemia completely.
Pages: 17-20  |  1674 Views  137 Downloads


The Pharma Innovation Journal
How to cite this article:
Grydguk T.І.. Differential Access to Treating Of Drug-Induced Hepatotoxicity in Patients with Chronic Lymphocytic Leukemia. Pharma Innovation 2015;4(1):17-20.

Call for book chapter